Born to survive: how cancer cells resist CAR T cell therapyJean Lemoine, Roch Houot|Journal of Hematology & Oncology|2021Cited by 121
Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Marie Sébert, Laëtitia Largeaud et al.|Blood|2022Cited by 80
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Marco Ruella, Melody T. Tan et al.|Cancer Cell|2025Cited by 47